Nausea and Vomiting
Etiology
Gastrointestinal Disease
Infection
Metabolic
- Hyponatremia (see Hyponatremia)
- Epidemiology: nausea/vomiting is typically an early sign in hyponatremia, occuring when the serum sodium falls below 125-130 mEq/L
- Lactic Acidosis (see Lactic Acidosis)
Drug
- Abacavir (see Abacavir)
- Alpha-1 Antitrypsin (Aralast, Glassia, Prolastin, Zemaira) (see Alpha-1 Antitrypsin): occurs in 1.7-4.7% of cases
- Amiodarone (see Amiodarone)
- Azacitidine (5-Azacytidine, Vidaza) (see Azacitidine)
- Ceftaroline (Teflaro, Zinfloro) (see Ceftaroline)
- Chemotherapeutic Agents
- Cytokine Release Syndrome (see Cytokine Release Syndrome)
- Digoxin Intoxication (see Digoxin)
- Eculizumab (Soliris) (see Eculizumab)
- Etomidate (Amidate) (see Etomidate)
- Metformin (see Metformin)
- N-Acetylcysteine (Mucomyst, Acetadote, Fluimucil, Parvolex) (see N-Acetylcysteine)
- Associated with inhaled, oral, and intravenous administration
- Nivolumab (Opdivo) (see Nivolumab)
- Opiates (see Opiates)
- Oseltamivir (Tamiflu) (see Oseltamivir): nausea/vomiting occurs in 19% of cases
- Raltegravir (see Raltegravir)
- Risperidone (Risperdal) (see Risperidone)
- Theophylline Intoxication (see Theophylline)
- Tigecycline (see Tigecycline)
Toxin
Other
Treatment (Anti-Emetics)
Lorazepam (Ativan) (see Lorazepam)
Prochlorperazine (Compazine) (see Prochlorperazine)
- Agents
- Dolasetron (Anzemet) (see Dolasetron)
- Granisetron (Kytril, Sancuso) (see Granisetron)
- Metoclopramide (Reglan) (see Metoclopramide)
- Dopamine D2 Receptor Antagonist (see Dopamine Receptor Antagonists): at low dose
- Central Dopamine D2 Receptors: located in the central nervous system chemoreceptor trigger zone
- Peripheral Dopamine D2 Receptors
- Mixed Serotonin 5-HT3 Receptor Antagonist and Serotonin 5-HT4 Receptor Agonist (see Serotonin 5-HT3 Receptor Antagonists, [[Serotonin 5-HT3 Receptor Antagonists]]): at high dose
- Enhances Acetylcholine Release and Stimulates Cholinergic Receptors on Gastric Smooth Muscle
- Ondansetron (Zofran) (see Ondansetron)
- Tropisetron (Navoban)
References
- American Gastroenterological Association medical position statement: nausea and vomiting. Gastroenterology. 2001 Jan;120(1):261-3 [MEDLINE]